Acne Vulgaris. Acne vulgaris
Conditions
Interventions
Intervention 1: Intervention group: Treatment with 2% spironolactone topical solution made by an experienced pharmacist twice a day for 3 months. Intervention 2: Control group: Treatment with 2% clind
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: People with mild to moderate acne 18 years old and above
Exclusion criteria
Exclusion criteria: Pregnant and lactating women Known hypersensitivity to clindamycin History of using oral isotretinoin, laser or chemical peeling in the last 6 months History of taking oral estrogen compounds in the last 3 months History of using retinoid or antibiotics during the last month History of using antimicrobial soaps or topical peels during the last two weeks Chronic skin diseases such as psoriasis, lichen planus, vitiligo Weakness of the immune system or the use of immunosuppressive drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acne Severity. Timepoint: Beginning of trial,1 month,2 months and 3 months after treatment. Method of measurement: Global Acne Grading System. | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency and type of acne lesions. Timepoint: Beginning of trial,1 month,2 months and 3 months after treatment. Method of measurement: Counting type and number of lesions. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBahareh Ebrahimi
Hamedan University of Medical Sciences
Outcome results
None listed